2020
DOI: 10.5334/gh.367
|View full text |Cite
|
Sign up to set email alerts
|

High Sensitivity C-Reactive Protein Predictive Value for Cardiovascular Disease: A Nested Case Control from Isfahan Cohort Study (ICS)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 37 publications
(52 reference statements)
2
16
0
Order By: Relevance
“…However, there are only a few studies investigating the serum levels of these cytokines and their results are conflicting. Hs‐CRP is a very sensitive marker of systemic inflammation and is the most widely evaluated biomarker for CVD risk prediction 38 . In this study, we report higher serum IL‐1β, IL‐6, TNF‐α, and hs‐CRP levels in patients with rosacea compared with the control group.…”
Section: Discussionsupporting
confidence: 50%
“…However, there are only a few studies investigating the serum levels of these cytokines and their results are conflicting. Hs‐CRP is a very sensitive marker of systemic inflammation and is the most widely evaluated biomarker for CVD risk prediction 38 . In this study, we report higher serum IL‐1β, IL‐6, TNF‐α, and hs‐CRP levels in patients with rosacea compared with the control group.…”
Section: Discussionsupporting
confidence: 50%
“…An appropriate approach toward HF management requires knowledge of mechanisms and precipitating factors contributing to its development [ 5 ]. Recently, biomarkers have been introduced to help physicians predicting clinical outcomes and improve the current knowledge about the precise pathophysiology of cardiovascular disorders, including HF [ 6 8 ]. Some of these biomarkers' prognostic values have been extensively investigated over the past decades [ 7 , 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…Future multi-center, large sample-size studies with long-term follow-up regarding the medical and socio-economic effects of CRP-guided interventions may be helpful. Since hsCRP is more sensitive to be quantified with a low detect threshold, 31 it might act as a more valuable biomarker than CRP in the clinical risk-stratification and prognostic prediction model.…”
Section: Discussionmentioning
confidence: 99%